XML 92 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Share-based payments (Tables)

12 Months Ended

Dec. 31, 2023

Share-based payments

Schedule for expense recognized for the equity-settled programs

The expense recognized for share-based payments during the years ended December 31 is as follows:

​	​	​	​	​	​	​
​		2021		2022		2023
​	​	EUR k	​	EUR k	​	EUR k
Prior VSOP		(624)		(131)		(10)
New VSOP		(572)		95		(19)
LTIP Stock Options		(12,472)		(5,562)		(2,944)
LTIP RSUs		(705)		(3,108)		(4,072)
RSU Supervisory board		(566)		(478)		(652)
Total		(14,939)		(9,184)		(7,697)

Prior VSOP

Share-based payments

Schedule of reconciliation of outstanding awards

​

​	​	​	​	​	​	​
​		2021		2022		2023
Outstanding at the beginning of the period	​	7,951,265	​	6,426,365	​	5,614,246
Granted during the period		—	​	—	​	—
Forfeited during the period		—	​	(34,859)	​	(11,091)
Exercised during the period	​	(1,524,900)	​	(777,260)	​	—
Outstanding at the end of the period		6,426,365	​	5,614,246	​	5,603,155
Thereof vested		6,365,422	​	5,509,886	​	5,588,513
Thereof exercisable		none	​	none	​	none

Schedule of share-based payments expenses

The expense recognized for this share-based payment plan during the years ended December 31 is as follows:

​

​	​	​	​	​	​	​
​	​	2021	​	2022	​	2023
​		EUR k		EUR k		EUR k
Cost of Sales	​	—	​	—	​	(9)
Selling and distribution expenses	​	(25)	​	(8)	​	(6)
Research and development expenses		(369)		(45)		46
General and administrative expenses		(230)		(78)		(41)
Total		(624)		(131)		(10)

New VSOP

Share-based payments

Schedule of reconciliation of outstanding awards

The number of awards in the New VSOP program granted to key employees developed as follows:

​

​	​	​	​	​	​	​
​		2021		2022		2023
Outstanding at the beginning of the period	​	906,595		349,424		102,108
Granted during the period	​	—		—		—
Forfeited during the period	​	​	​	(99,696)	​	—
Exercised during the period	​	(557,171)	​	(147,620)	​	(69,246)
Outstanding at the end of the period		349,424	​	102,108	​	32,862
Thereof vested	​	88,464	​	59,942	​	32,862
​	​	​	​	​	​	​
Thereof exercisable		88,464	​	59,942	​	—

Schedule of share-based payments expenses

The expense recognized for employee services received during the years ended December 31, 2023, 2022, and 2021 is shown in the following table:

​

​	​	​	​	​	​	​
​		2021		2022		2023
​	​	EUR k	​	EUR k		EUR k
Research and development expenses		(349)	​	69	​	(31)
Selling and distribution expenses		(188)	​	23	​	—
General and administrative expenses		(35)	​	3	​	12
Total		(572)	​	95	​	(19)

Former Chief Executive Officer Grant

Share-based payments

Schedule of inputs used in the measurement of the fair value at grant date

​

​	​	​	​
Weighted average fair value per option		EUR 57.40	​
Weighted average share price (10-days VWAP before grant date)		EUR 50.01	​
Exercise price (USD 11.90)		EUR 10.04	​
Expected volatility (%)		62.06	%
Expected life (years)		1.82	​
Risk-free interest rate (%)		0.07 - 1.48	%

First tranche:

​

​	​	​	​
Weighted average fair value per option		EUR 48.27	​
Weighted average share price (actual 10-days VWAP before grant date, USD 81.03)		EUR 67.12	​
Exercise price (USD 52.96)		EUR 43.87	​
Expected volatility (%)		62.27	%
Expected life (years)		1.78	​
Risk-free interest rate (%)		0.07 - 1.50	%

​

Second tranche:

​

​	​	​	​
Weighted average fair value per option		EUR 24.36	​
Weighted average share price (estimated by Monte Carlo simulation to be USD 98.36)		EUR 81.48	​
Exercise price (estimated by Monte Carlo simulation to be USD 98.36)		EUR 81.48	​
Expected volatility (%)		62.27	%
Expected life (years)		2.23	​
Risk-free interest rate (%)		0.07 - 1.50	%

​

Third tranche:

​

​	​	​	​
Weighted average fair value per option		EUR 20.01	​
Weighted average share price (estimated by Monte Carlo simulation to be USD 98.57)		EUR 81.65	​
Exercise price (estimated by Monte Carlo simulation to be USD 98.57)		EUR 81.65	​
Expected volatility (%)		62.27	%
Expected life (years)		2.66	​
Risk-free interest rate (%)		0.07 - 1.50	%

​

​	​	​	​
Weighted average fair value per option		EUR 0.65	​
Weighted average share price (30-days VWAP after grant date)		EUR 77.73	​
Exercise price (USD 88.16)		EUR 77.73	​
Expected volatility (%)		73.00	%
Expected life (years)		2.15	​
Risk-free interest rate (%)		0.08 - 0.49	%

​

​	​	​	​
Weighted average fair value per option		EUR 17.56	​
Weighted average share price (20-day VWAP before grant date)		EUR 56.51	​
Exercise price (USD 84.03)		EUR 70.92	​
Expected volatility (%)	​	70.95	%
Expected life (years)		4.5	​
Risk-free interest rate (%)	​	0.099  –  0.903	%

​

​	​	​	​
Weighted average fair value per option		EUR 17.56	​
Weighted average share price (20-days VWAP before grant date)		EUR 41.81	​
Exercise price (USD 84.03)		EUR 46.16	​
Expected volatility (%)	​	75.13	%
Expected life (years)		4.6	​
Risk-free interest rate (%)	​	0.075  –  0.704	%

​

​	​	​	​
Weighted average fair value per option		EUR 14.31	​
Weighted average share price (30-days VWAP after grant date)		EUR 30.67	​
Exercise price (USD 34.87)		EUR 30.67	​
Expected volatility (%)		72.17	%
Expected life (years)		2.16	​
Risk-free interest rate (%)		0.40 - 1.15	%

​

​	​	​	​
Weighted average fair value per option		EUR 4.86	​
Weighted average share price (10 - day VWAP before grant date)		EUR 15.07	​
Exercise price (USD 19.35)		EUR 18.37	​
Expected volatility (%)		73.87 - 86.09	%
Expected life (years)		2.33	​
Risk-free interest rate (%)		2.34 - 3.21	%

​

​	​	​	​
Weighted average fair value per option		EUR 6.81
Weighted average share price (10-days VWAP before grant date)	​	EUR 17.45
Exercise price (USD 19.28)		EUR 17.45	​
Expected volatility (%)		50.91	%
Expected life (years)		2.16	​
Risk-free interest rate (%)		2.67	%

​

​	​	​	​
Weighted average fair value per option		EUR 3.55	​
Weighted average share price (10-day VWAP before grant date)		EUR 6.12	​
Exercise price (USD 6.66)		EUR 6.12	​
Expected volatility (%)		75.0	%
Expected life (years)		3.39	​
Risk-free interest rate (%)		3.70	%

Restricted Stock Units

Share-based payments

Schedule of share-based payments expenses

​

​	​	​	​	​	​	​
​		2021		2022		2023
​	​	EUR k	​	EUR k	​	EUR k
Cost of Sales	​	—	​	—	​	(331)
Research and development expenses		(240)		(909)		(1,719)
Selling and distribution expenses		(82)		(199)		(269)
General and administrative expenses		(383)		(2,000)		(1,753)
Total		(705)		(3,108)		(4,072)

​

X

- Definition

Disclosure of expense recognized for employee services explanatory.

+ References

No definition available.

+ Details

Name:	cvac_DisclosureOfExpenseRecognizedForEmployeeServicesExplanatory
Namespace Prefix:	cvac_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The tabular disclosure of expense recognized for the programs.

+ References

No definition available.

+ Details

Name:	cvac_ScheduleOfExpenseRecognizedForProgramsTableTextBlock
Namespace Prefix:	cvac_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 45
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cvac_VirtualSharesProgramIMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cvac_VirtualSharesProgramIiMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cvac_OptionsGrantedToThenChiefExecutiveOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cvac_RestrictedStockUnitsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: